(Q34128850)

31 July 2017

1 reference

title

Gestational trophoblastic disease. (English)

1 reference

gestational trophoblastic disease

31 July 2017

main subject

1 reference

Neil J Sebire

2

0 references

author name string

Michael J Seckl

series ordinal

1

1 reference

31 July 2017

Ross S Berkowitz

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

29 July 2010

1 reference

31 July 2017

1 reference

31 July 2017

volume

376

1 reference

31 July 2017

issue

9742

1 reference

31 July 2017

page(s)

717-729

1 reference

The pathology of choriocarcinoma

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Isolation of fetal trophoblast cells from peripheral blood of pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Recent advances in gestational trophoblastic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Risk factors for complete molar pregnancy from a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Dietary factors and risk of trophoblastic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Hydatidiform mole in England and Wales 1973-83.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Risk of partial and complete hydatidiform molar pregnancy in relation to maternal age

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Repetitive hydatidiform mole with different male partners

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Placental site trophoblastic tumour arising from a partial hydatidiform mole

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Choriocarcinoma and partial hydatidiform moles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Gestational trophoblastic neoplasia management: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Oral Contraceptive Use and Risk of Gestational Trophoblastic Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Relationship of oral contraception to development of trophoblastic tumour after evacuation of a hydatidiform mole

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Influence of oral contraceptives in the development of post-molar trophoblastic neoplasia--a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Androgenetic origin of hydatidiform mole

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

HLA antigens in husband-wife pairs with trophoblastic tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Application of gene amplification by polymerase chain reaction to genetic analysis of molar mitochondrial DNA: The detection of anuclear empty ovum as the cause of complete mole

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Genetic mapping of a maternal locus responsible for familial hydatidiform moles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

A recurrent intragenic genomic duplication, other novel mutations in NLRP7 and imprinting defects in recurrent biparental hydatidiform moles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Identification of 13 novel NLRP7 mutations in 20 families with recurrent hydatidiform mole; missense mutations cluster in the leucine-rich region.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

The syndromes of hydatidiform mole. I. Cytogenetic and morphologic correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

A prospective genetic study of complete and partial hydatidiform moles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

A flow cytometric study of 137 fresh hydropic placentas: correlation between types of hydatidiform moles and nuclear DNA ploidy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Histopathological diagnosis of partial and complete hydatidiform mole in the first trimester of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Gestational trophoblastic disease: current management of hydatidiform mole.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Discrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57KIP2.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

The maternally transcribed gene p57KIP2 (CDNK1C) is abnormally expressed in both androgenetic and biparental complete hydatidiform moles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Rapid diagnosis and classification of hydatidiform moles with polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Complete hydatidiform mole and normal live birth: a novel case of confined placental mosaicism: Case report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

A complete hydatidiform mole coexisting with a normal fetus was confirmed by variable number tandem repeat (VNTR) polymorphism analysis using polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Intraplacental choriocarcinoma: experience from a tertiary referral center and relationship with infantile choriocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Placental site trophoblastic tumor: A study of 55 cases and review of the literature emphasizing factors of prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Discrepancies between commercially available immunoassays in the detection of tumour-derived hCG.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Human chorionic gonadotropin tests

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Differences in recognition of the 1st WHO international reference reagents for hCG-related isoforms by diagnostic immunoassays for human chorionic gonadotropin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Management and outcome of healthy women with a persistently elevated beta-hCG.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Sonographic evaluation of hydatidiform mole and its look-alikes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Sonographic appearance of first trimester complete hydatidiform moles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Appearance of molar pregnancy 9.5 weeks after conception. Use of transvaginal ultrasound for early diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Early ultrasound diagnosis and follow-up of molar pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Transvaginal sonographic diagnosis of a hydatidiform mole occurring two weeks after curettage for an incomplete abortion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Sonographic appearances of the partial hydatidiform mole

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Routine pre-evacuation ultrasound diagnosis of hydatidiform mole: experience of more than 1000 cases from a regional referral center

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

A prospective study of ultrasound screening for molar pregnancies in missed miscarriages

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

The diagnostic implications of routine ultrasound examination in histologically confirmed early molar pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Histomorphometric features of hydatidiform moles in early pregnancy: relationship to detectability by ultrasound examination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Routine terminations of pregnancy—should we screen for gestational trophoblastic neoplasia?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Clinical practice. Molar pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Hydatidiform mole coexistent with a twin live fetus: a national collaborative study in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Outcome of twin pregnancies with complete hydatidiform mole and healthy co-twin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Shortened duration of human chorionic gonadotrophin surveillance following complete or partial hydatidiform mole: evidence for revised protocol of a UK regional trophoblastic disease unit

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Guidelines following hydatidiform mole: a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Persistent trophoblast disease following partial molar pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Previous hydatidiform mole identified as the causative pregnancy of choriocarcinoma following birth of normal twins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

The impact of molecular genetic diagnosis on the management of women with hCG-producing malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Current management of gestational trophoblastic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Clinical outcome of micrometastasis in the lung in stage IA persistent gestational trophoblastic disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Does chest CT matter in the staging of GTN?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

The role of repeat uterine evacuation in trophoblast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

First line chemotherapy in low risk gestational trophoblastic neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Is lack of response to single-agent chemotherapy in gestational trophoblastic disease associated with dose scheduling or chemotherapy resistance?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Ten year's experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

The management and outcome of women with post-hydatidiform mole 'low-risk' gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l(-1).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Pulmonary embolism, pulmonary hypertension, and choriocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Central nervous system metastases of choriocarcinoma. 23 years' experience at Charing Cross Hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Gestational Choriocarcinoma Mimicking a Uterine Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Combination chemotherapy for high-risk gestational trophoblastic tumour

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT--25 years experiences of KRI-TRD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

EMA-CO chemotherapy for high-risk gestational trophoblastic neoplasia: a clinical analysis of 54 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Gestational trophoblastic disease with liver metastases: the Charing Cross experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Residual lung lesions after completion of chemotherapy for gestational trophoblastic neoplasia: should we operate?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

The prognosis of gestational trophoblastic neoplasia patient with residual lung tumor after completing treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

The management of recurrent and drug-resistant gestational trophoblastic neoplasia (GTN)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Secondary chemotherapy for high-risk gestational trophoblastic neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastati

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Gestational choriocarcinoma: an unusual presentation with response to gemcitabine and surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Treatment of resistant gestational choriocarcinoma with taxol: a report of two cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Remission of refractory gestational trophoblastic disease with high-dose paclitaxel.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Successful salvage therapy of resistant gestational trophoblastic disease with ifosfamide and paclitaxel.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Fertility-sparing partial hysterectomy for placental-site trophoblastic tumour

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Treatment of placental site trophoblastic tumor with hysterotomy and uterine reconstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Placental site trophoblastic tumor: outcome of five cases including fertility preserving management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Case of PSTT treated with chemotherapy followed by open uterine tumor resection to preserve fertility

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Chemotherapy for gestational trophoblastic tumours hastens menopause by 3 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

The effect of early pregnancy following chemotherapy on disease relapse and foetal outcome in women treated for gestational trophoblastic tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960280-2

7 January 2021

10.1016/S0140-6736(10)60280-2

Identifiers

DOI

1 reference

31 July 2017

1 reference